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Introduction 
Since the study of Bunney and Fawcett (1965) showing increased 
levels of 24-hour urinary 17-hydroxycorticosteroids in patients 
who completed suicide, several investigators assessing plasma 
concentrations and urinary excretion of cortisol have suggested 
hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in 
patients with suicidal behavior (Bunney et al 1969; Ostroff et al 
1982; Prasad 1985). Postmortem studies have demonstrated corti- 
cotropin-releasing hormone (CRH) hypersecretion in patients who 
completed suicide (Nemeroff et al 1988; Arato et al 1989). Several 
studies have also reported a relationship between cortisol nonsup- 
pression in the dexamethasone suppression test (DST) and a his- 
tory of suicide attempts (Coryell and Schlesser 1981 ; Targum et al 
1983; Robbins and Alessi 1985; Normal et al 1990; Pfeffer et al 
1991). More recently, Roy (1992) failed to show a difference 
between suicide attempters and nonattempters for cerebrospinal 
fluid levels of CRH, postdexamethasone plasma cortisol concen- 
trations, or 24-hour urinary-free cortisol levels; however, patients 
with a history of violent suicide attempt exhibited a higher 4:00 PM 
postdexamethasone cortisol level and a more frequent DST non- 
suppression than nonviolent suicide attempters. In this context, the 
aim of the present study was to test the hypothesis that HPA axis 
overactivity, as assessed by the postdexamethasone cortisol level, 
could be in relationship with violent suicide attempts. 
Methods 
The study was performed in 33 DSM-III-R (APA 1987) unipolar 
major depressive inpatients with a history of suicide attempt dur- 
ing the current episode, and representing consecutive admissions 
to the Psychiatric Unit of the University Hospital of Liege, Bel- 
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gium. The sample comprised 23 male and 10 female patients with 
a mean age of 39.7 years (SD ± 11.5). These patients were individ- 
ually matched for gender, age (within 3 years), and, in the case of 
women, menopausal status, with 33 major depressive inpatients 
without history of suicidal behavior. All patients had a score of at 
least 18 on the 17-item Hamilton depression scale (Hamilton 
1960) at the end of a drug-free period of at least 2 weeks. The two 
groups did not differ in mean age or weight. 
Past history of suicide attempt was based on interviews of the 
patients and their family. Only suicidal behavior with a real intent 
to die was recorded. Suicide attempts were classified as violent 
(hanging, drowning, deep cuts, and shooting) or nonviolent (drug 
overdoses and superficial wrist cuts). The patients were free of 
medical illness as evidenced by history, medical examination, 
EKG, chest X-ray, EEG, and routine laboratory tests. 
The DST was performed according to the simplified procedure 
described by Carroll et al (1981). Each patient received 1 mg of 
dexamethasone at 11:00 PM under direct nurse supervision, and a 
blood sample was collected at 4:00 PM the next day. We also 
measured 8:00 AM plasma cortisol levels 1 day before the DST 
procedure. Concentrations of total cortisol were determined by 
radioimmunoassay (RIA), with intra- and interassay coefficients 
of variation of 4.3 % and 8.3%, respectively (Sulon et al 1978). We 
considered DST nonsuppression for all cortisol values higher than 
5 Ixg/dl (Carroll et al 1981). The protocol was approved by the 
Ethical Committee of the University of Liege Medical School, all 
patients were fully informed of the study and gave their consent. 
The cortisol levels after dexamethasone of patients with and 
without history of suicide attempt were compared using analysis of 
variance (ANOVA), whereas, the comparison of violent and non- 
violent suicide attempters by covarying for age and melancholia. 
We also used the chi square procedure. 
Results  
There was no significant difference between suicide attempters and 
nonattempters for the severity of depression as assessed by the Ham- 
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ilton depression scale scores: 25.5 -+ 6.0 vs. 24.8 -+ 3.5 (F = .4, p = .5). 
Moreover, violent attempters were not more severely depressed than 
nonviolent attempters: (for HAMD scores) 27.0-+6.5 vs. 24.4-+5.4 
(F = 1.6,p = .2). There was no significant effect of age (r =. 10, NS) or 
melancholia (r = .08, NS) on postdexamethasone cortisol levels in 
the total population of depressed patients. 
There was no statistically significant difference between suicide 
attempters and nonattempters for 4:00 PM postdexamethasone cor- 
tisol levels: 6.4-+6.4 laJdl vs. 6.8_+6.4 ~/dl (F=  .1, df= 2,64, p.8); 
or for 8:00 AM predexamethasone cortisol levels: 16.5 -+5.4 p~g/dl 
vs. 17.4-+9.4 ixg/dl (F = 1.7, p = .2). Fifteen of the 33 (45%) 
patients with a history of suicide attempts were nonsuppressors 
compared to 16 of the 33 (48%) nonattempters (chi square = 0.0, 
df= l , p =  .8). 
Mean postdexamethasone cortisol levels did not exhibit any sig- 
nificant difference between violent (n = 14) and nonviolent (n = 19) 
attempters: 5.7-+4.1 I~g/dl vs. 6.8+--7.8 Ixg/dl (F = 0.5, df= 4,29, p = 
.5). Moreover, patients with a history of violent suicide attempts 
exhibited more frequent DST nonsuppression (8/14 = 57%) than 
nonviolent attempters (7/19 = 37%), but this difference did not reach 
statistical significance (chi square = 1.33, df= 1, p = .25). 
Discussion 
In our study, we did not find any relationship between 
4:00 PM postdexamethasone cortisol levels and history of 
References 
American Psychiatric Association ( 1987): Diagnostic and Statisti- 
cal Manual of  Mental Disorders, 3rd ed rev., Washington DC: 
American Psychiatric Association. 
Arato M, Banki CM, Bissette G, Nemeroff CB (1989): Elevated 
CSF CRF in suicide victims. Biol Psychiatry 29:355-359. 
Brown R, Mason B, Stoll P, et al (1986): Adrenocortical function 
and suicidal behavior in depressive disorders. Psychiatry Res 
17:317-323. 
Bunney WE Jr, Fawcett JA (1965): Possibility of a biochemical 
test for suicidal potential. Arch Gen Psychiatry, 13:232-239. 
Bunney WE Jr, Fawcett JA, Davis JH, Gifford S (1969): Further 
evaluation of urinary 17-hydroxycorticostero~'ds in suicidal pa- 
tients. Arch Gen Psychiatry 21:138-150. 
Carroll B J, Feinberg M, Greden JF, et al (1981 ): A specific labora- 
tory test for the diagnosis of melancholia. Arch Gen Psychiatry 
38:15-22. 
Coryell W, Schleser MA (1981): Suicide and the dexamethasone 
suppression test in unipolar depression. Am J Psychiatry 
138:1120-1121. 
Hamilton M (1960): A rating scale for depression. J Neurol Neuro- 
surg Psychiatry 23:56-62. 
Kocsis JH, Kennedy S, Brown RD, Mann JJ, Mason B (1986): 
Suicide and adrenocortical function. Psychopharmacol Bull 
22:650-655. 
Nemeroff CB, Owens M J, Bissette G, Andhorn AC, Stanley M 
(1988): Reduced corticotropin releasing factor binding sites in 
the frontal cortex of suicide victims. Arch Gen Psychiatry 
45:577-579. 
Norman WH, Brown WA, Miller IW, Keitner GI, Overholser JC 
suicide attempts in major depression. Similarly, there was no 
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this difference was not statistically significant. Thus, these re- 
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Some differences in the methodological approach could explain 
these discrepancies. First, all of our depressed patients had at- 
tempted suicide during the current depressive episode. Second, 
our sample included more violent suicide attempters (n = 14) than 
in the study of Roy (n = 7). 
In conclusion, these results suggest that DST nonsuppression 
cannot be considered as a biological marker of suicidal behavior. 
In particular, hyperactivity of HPA axis in depression does not 
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